Correlation Between Bionoid Pharma and Braskem SA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bionoid Pharma and Braskem SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionoid Pharma and Braskem SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bionoid Pharma and Braskem SA Class, you can compare the effects of market volatilities on Bionoid Pharma and Braskem SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionoid Pharma with a short position of Braskem SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionoid Pharma and Braskem SA.

Diversification Opportunities for Bionoid Pharma and Braskem SA

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Bionoid and Braskem is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Bionoid Pharma and Braskem SA Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Braskem SA Class and Bionoid Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionoid Pharma are associated (or correlated) with Braskem SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Braskem SA Class has no effect on the direction of Bionoid Pharma i.e., Bionoid Pharma and Braskem SA go up and down completely randomly.

Pair Corralation between Bionoid Pharma and Braskem SA

Given the investment horizon of 90 days Bionoid Pharma is expected to generate 13.0 times more return on investment than Braskem SA. However, Bionoid Pharma is 13.0 times more volatile than Braskem SA Class. It trades about 0.14 of its potential returns per unit of risk. Braskem SA Class is currently generating about -0.34 per unit of risk. If you would invest  25.00  in Bionoid Pharma on September 1, 2024 and sell it today you would lose (2.00) from holding Bionoid Pharma or give up 8.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Bionoid Pharma  vs.  Braskem SA Class

 Performance 
       Timeline  
Bionoid Pharma 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Bionoid Pharma are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Bionoid Pharma reported solid returns over the last few months and may actually be approaching a breakup point.
Braskem SA Class 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Braskem SA Class has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Bionoid Pharma and Braskem SA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bionoid Pharma and Braskem SA

The main advantage of trading using opposite Bionoid Pharma and Braskem SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionoid Pharma position performs unexpectedly, Braskem SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Braskem SA will offset losses from the drop in Braskem SA's long position.
The idea behind Bionoid Pharma and Braskem SA Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation